Income Statement (TTM)
Eagle Pharmaceuticals, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 186 | 188 | 183 | 189 | 179 | 172 | 246 | 272 | 298 | 317 | 267 | 258 |
| Change (%) | 0.89 | -2.54 | 3.38 | -5.32 | -4.24 | 43.50 | 10.57 | 9.57 | 6.16 | -15.66 | -3.55 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 45 | 45 | 49 | 46 | 42 | 42 | 59 | 72 | 87 | 95 | 84 | 78 |
| Change (%) | 2.13 | 6.71 | -4.90 | -8.08 | -0.55 | 40.07 | 21.85 | 21.38 | 8.65 | -11.01 | -8.06 | |
| % of Revenue | 23.91 | 24.21 | 26.51 | 24.38 | 23.68 | 24.59 | 24.00 | 26.45 | 29.30 | 29.99 | 31.64 | 30.16 |
| Gross Operating Profit | 142 | 142 | 135 | 143 | 137 | 129 | 187 | 200 | 211 | 222 | 183 | 180 |
| Change (%) | 0.50 | -5.50 | 6.37 | -4.44 | -5.39 | 44.62 | 7.00 | 5.32 | 5.13 | -17.64 | -1.47 | |
| % of Revenue | 76.09 | 75.79 | 73.49 | 75.62 | 76.32 | 75.41 | 76.00 | 73.55 | 70.70 | 70.01 | 68.36 | 69.84 |
| SG&A | 80 | 79 | 76 | 75 | 76 | 75 | 78 | 79 | 82 | 87 | 93 | 103 |
| Change (%) | -2.21 | -3.02 | -1.74 | 1.05 | -0.48 | 3.06 | 1.80 | 4.15 | 5.86 | 6.63 | 10.35 | |
| % of Revenue | 43.18 | 41.85 | 41.64 | 39.58 | 42.25 | 43.91 | 31.53 | 29.03 | 27.60 | 27.52 | 34.79 | 39.81 |
| R&D | 33 | 31 | 36 | 38 | 57 | 51 | 43 | 45 | 31 | 34 | 37 | 36 |
| Change (%) | -5.84 | 15.79 | 7.79 | 48.05 | -9.86 | -15.95 | 3.54 | -31.29 | 11.19 | 9.28 | -4.31 | |
| % of Revenue | 17.56 | 16.39 | 19.48 | 20.31 | 31.75 | 29.89 | 17.51 | 16.39 | 10.28 | 10.77 | 13.95 | 13.84 |
| OpEx | 158 | 155 | 160 | 159 | 175 | 169 | 180 | 196 | 200 | 216 | 215 | 216 |
| Change (%) | -1.74 | 3.58 | -0.58 | 9.73 | -3.54 | 6.53 | 8.80 | 2.41 | 7.89 | -0.70 | 0.56 | |
| % of Revenue | 84.66 | 82.45 | 87.63 | 84.27 | 97.68 | 98.39 | 73.04 | 71.87 | 67.18 | 68.27 | 80.38 | 83.81 |
| Operating Income | 29 | 33 | 23 | 30 | 4 | 3 | 66 | 77 | 98 | 100 | 52 | 42 |
| Change (%) | 15.39 | -31.28 | 31.40 | -86.01 | -33.49 | 2,296.93 | 15.34 | 27.87 | 2.62 | -47.84 | -20.42 | |
| % of Revenue | 15.34 | 17.55 | 12.37 | 15.73 | 2.32 | 1.61 | 26.96 | 28.13 | 32.82 | 31.73 | 19.62 | 16.19 |
| Interest Expense | -3 | -3 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -4 | -5 | -6 |
| Change (%) | -10.24 | -18.12 | -17.25 | -5.33 | -1.09 | -3.43 | 8.23 | 43.94 | 64.43 | 28.43 | 17.25 | |
| % of Revenue | -1.54 | -1.37 | -1.15 | -0.92 | -0.92 | -0.95 | -0.64 | -0.63 | -0.82 | -1.28 | -1.95 | -2.36 |
| Net Income | 5 | 12 | 14 | 18 | 6 | -9 | 36 | 23 | 21 | 36 | -3 | 12 |
| Change (%) | 142.84 | 20.44 | 26.79 | -69.27 | -253.34 | -515.58 | -36.43 | -6.62 | 67.48 | -107.48 | -548.16 | |
| % of Revenue | 2.65 | 6.38 | 7.89 | 9.68 | 3.14 | -5.03 | 14.56 | 8.37 | 7.14 | 11.26 | -1.00 | 4.64 |
Source: Capital IQ
